Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 974 results
Cancer cell dividing

Getting to grips with metastasis means understanding the evolutionary mechanisms behind this complex biology, says Dr Simone Zaccaria... Getting to grips with metastasis means understanding the evolutionary mechanisms behind this complex biology, says Dr Simone Zaccaria...

by Cancer Research UK | In depth | 27 February 2024

27 February 2024

A close up of the UK on a globe, with a red pin marking its location

New research from the International Cancer Benchmarking Partnership shows people in the UK were treated with chemotherapy and radiotherapy less often, and faced longer waits to start treatment New research from the International Cancer Benchmarking Partnership shows people in the UK were treated with chemotherapy and radiotherapy less often, and faced longer waits to start treatment

by Jacob Smith | Analysis | 27 February 2024

27 February 2024

More Research, Less Cancer over an image of a researcher

Cancer Research UK has joined forces with a coalition of the world’s most renowned voices in the research community to call on high-value donors and philanthropists to help tackle cancer. Cancer Research UK has joined forces with a coalition of the world’s most renowned voices in the research community to call on high-value donors and philanthropists to help tackle cancer.

by Cancer Research UK | News | 22 February 2024

22 February 2024

A microscope image showing cells affected by Barrett's oesophagus, a precancer that can lead to oesophageal cancer.

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

by Amy Warnock | Analysis | 9 February 2024

9 February 2024

Cells with nuclei in blue and mitochondria (energy factories) in green.

Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people. Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people.

by Tim Gunn | Analysis | 31 January 2024

31 January 2024

Ben Hood

We caught up with Ben Hood to find out how research nurses are evolving and the challenges they face…   We caught up with Ben Hood to find out how research nurses are evolving and the challenges they face…  

by Phil Prime | Interview | 17 January 2024

17 January 2024

Breast cancer cells taken as part of a biopsy shown under the microscope

New research we've funded has found that breast cancers can break down molecules in their support system to use as a source of nutrients. As healthy cells can't use this chemical pathway to make food, it could lead to a new targeted breast cancer treatment. New research we've funded has found that breast cancers can break down molecules in their support system to use as a source of nutrients. As healthy cells can't use this chemical pathway to make food, it could lead to a new targeted breast cancer treatment.

by Jacob Smith | Analysis | 17 January 2024

17 January 2024

A Cancer Research UK-funded researcher in the lab.

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

by Tim Gunn | News | 10 January 2024

10 January 2024

Multiple myeloma is an incurable malignancy of immunoglobulin-secreting plasma cells

Lessons must be learnt from the personalised medicine revolution in solid cancers if we are to push treatment of multiple myeloma forward Lessons must be learnt from the personalised medicine revolution in solid cancers if we are to push treatment of multiple myeloma forward

by Cancer Research UK | In depth | 8 January 2024

8 January 2024

Two researchers smiling as they work together in a lab

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

by Jacob Smith | In depth | 18 December 2023

18 December 2023

Antibody

Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug... Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug...

by Cancer Research UK | In depth | 12 December 2023

12 December 2023